Need all Congresses? Press Enter for expanded federal results.

HB 417

Maryland House of Delegates bill in Session 2026.

Status: passed_lower. Latest action: April 10, 2026.

Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine.

Bill ID MD-2026-HB-417
Session 2026
Status passed_lower
Committee Health; Finance
House of Delegates passed_lower 2026-04-10
Summary

Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act

Sponsor
Delegate Pippy
Official Source Back to Bills
Actions Timeline
Date Event Detail
2026-01-22 Introduced Bill introduced
2026-02-23 Status passed_lower
2026-04-10 Latest Action In the Senate - Favorable Report by Finance
More Bills From This Sponsor
More Bills In This Topic
Related Topics
Same Topic Bills From Other States